ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01393340
Recruitment Status : Completed
First Posted : July 13, 2011
Last Update Posted : July 13, 2011
Sponsor:
Collaborator:
Novartis Pharma AG, Switzerland
Information provided by:
University Hospital, Ghent

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2008
  Actual Study Completion Date : December 2009